1.99
1.49%
-0.03
After Hours:
1.99
Incannex Healthcare Inc stock is traded at $1.99, with a volume of 2,877.
It is down -1.49% in the last 24 hours and up +13.07% over the past month.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
See More
Previous Close:
$2.02
Open:
$2
24h Volume:
2,877
Relative Volume:
0.10
Market Cap:
$35.11M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-10.83
EPS:
-0.1837
Net Cash Flow:
-
1W Performance:
-2.93%
1M Performance:
+13.07%
6M Performance:
-44.57%
1Y Performance:
+75.08%
Incannex Healthcare Inc Stock (IXHL) Company Profile
Name
Incannex Healthcare Inc
Sector
Phone
61 409 840 786
Address
401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA
Incannex Healthcare Inc Stock (IXHL) Latest News
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - StockTitan
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat
Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review
Incannex secures financing deal valued at US$60 million - Mugglehead
Incannex $60 Million Deal With Arena For Late-Stage Drug TrialsIncannex Healthcare (NASDAQ:IXHL) - Benzinga
Incannex Healthcare secures $60 million funding via equity and debt - Investing.com
Incannex Healthcare secures $60 million funding via equity and debt By Investing.com - Investing.com UK
Incannex Healthcare lands $60 million financing deal - Green Market Report
Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - GlobeNewswire
Incannex secures $60 million in funding for clinical trials - Investing.com
Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - StockTitan
Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest - MarketBeat
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - Defense World
Thinking about buying stock in Altimmune, UiPath, Incannex Healt - GuruFocus.com
Virtu Financial LLC Buys New Shares in Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World
4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com
FDA Review of PsiGAD2 IND complete; clinical trial for - GlobeNewswire
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety - Benzinga
Incannex Healthcare gets FDA nod for Phase 2 trial - Green Market Report
FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed - StockTitan
Tidal Investments LLC Buys New Stake in Incannex Healthcare Inc. (NASDAQ:IXHL) - MarketBeat
Tidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World
Dosing completed in 115 participant - GlobeNewswire
Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X - Yahoo Finance
Head to Head Review: Zai Lab (NASDAQ:ZLAB) vs. Incannex Healthcare (NASDAQ:IXHL) - Defense World
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 69.0% in June - MarketBeat
7 Best Psychedelic Stocks in 2024 | Investing - U.S News & World Report Money
Patient Dosing Begins in Phase 2/3 Trial for OSA Drug Candidate IHL-42X - Sleep Review
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - GlobeNewswire Inc.
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea - Yahoo Finance
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - GlobeNewswire Inc.
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder - Yahoo Finance
'Truly Remarkable’ Results Spur Incannex's Phase 2/3 Trials for Sleep Apnea Drug Candidate, Says CEO - Sleep Review
Incannex prepares IND submission for psychotherapy asset - Pharmaceutical Technology
symbol__ Stock Quote Price and Forecast - CNN
11 Best ASX Stocks To Buy Now - Yahoo Finance
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado - Quantisnow
Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison ... - Psychedelic Alpha
Incannex’s Psilocybin Clears Phase II Trial in Generalized Anxiety Disorder - BioSpace
Incannex Announces Positive Topline Results from Phase 2 - GlobeNewswire
How to buy Incannex Healthcare (IHL) shares in Australia - finder.com.au
Why Incannex Healthcare's (NASDAQ:IXHL) Earnings Are Weaker Than They Seem - Simply Wall St
Cannabis stocks eye US Federal legalisation after difficult year - Proactive Investors Australia
Incannex advances smoking cessation gum in FDA meeting By Investing.com - Investing.com Australia
Incannex Healthcare targeting $120 billion global addressable market with cannabinoid and psychedelic therapeutics - Proactive Investors Australia
Is Incannex Healthcare (NASDAQ:IXHL) In A Good Position To Invest In Growth? - Simply Wall St
Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne - Mugglehead
Incannex Healthcare Inc Share PriceIXHL, RNS News, Articles, Quotes, & Charts (NASDAQ:IXHL) - Proactive Investors UK
Incannex Healthcare Inc Share PriceIXHL, RNS News, Articles, Quotes, & Charts (NASDAQ:IXHL) - Proactive Investors Australia
Incannex begins dosing in Phase II rheumatoid arthritis drug trial - Clinical Trials Arena
Incannex Healthcare Inc Stock (IXHL) Financials Data
There is no financial data for Incannex Healthcare Inc (IXHL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):